We are live on ! Find out more
RGN

REGENERX BIOPHARMACEUTICALS
RGN

Delisted

RGN was delisted on the 22nd of December, 2010.

Back to rankings

2 hedge funds and large institutions have $57K invested in REGENERX BIOPHARMACEUTICALS in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

8% more capital invested

Capital invested by funds: $53K → $57K (+$4K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WJWM
1
Williams Jones Wealth Management
New York
$57K – – –

RGN Hedge Fund Activity: Q2 2021 in Review

2 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q2 2021, worth a combined $57K — up 7.5% from $53K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RGN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held REGENERX BIOPHARMACEUTICALS (RGN) as of Q2 2021, up from 1 in Q1 2021.
  • Funds reported $57K of REGENERX BIOPHARMACEUTICALS stock for Q2 2021, up 7.5% quarter-over-quarter.
  • 1 fund opened new REGENERX BIOPHARMACEUTICALS positions in Q2 2021 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2021.